Close

Regulus Therapeutics (RGLS) Reports Interim RG-101 Results

October 22, 2014 7:50 AM EDT Send to a Friend
Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login